Loading...
GETI B logo

Getinge AB (publ)OM:GETI B Stock Report

Market Cap SEK 60.7b
Share Price
SEK 222.90
My Fair Value
SEK 235.63
5.4% undervalued intrinsic discount
1Y12.3%
7D2.8%
Portfolio Value
​
View

Getinge AB (publ)

OM:GETI B Stock Report

Market Cap: SEK 60.7b

Getinge (GETI B) Stock Overview

Provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. More details

GETI B fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance4/6
Financial Health6/6
Dividends4/6

Rewards

Trading at 48.1% below our estimate of its fair value

Earnings are forecast to grow 15.85% per year

Earnings grew by 21.5% over the past year

Trading at good value compared to peers and industry

Risk Analysis

Unstable dividend track record


GETI B Community Fair Values

Create Narrative

See what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.

GETI B logo
Getinge

Advanced Digital Health And Infection Control Will Drive Future Markets

Key Takeaways Strong demand in core healthcare segments and increasing digital adoption support resilient revenue streams and margin improvement. Strategic acquisitions and operational efficiencies broaden product offerings and global presence, driving sustained top-line growth and profitability.
View narrative
SEK 235.71
FV
5.4% undervalued intrinsic discount
5.12%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
GETI B logo
Getinge

Aging Populations, Digital Health And Emerging Markets Will Spur Lifesaving Demand

Key Takeaways Faster-than-expected scaling of new assets and recurring, high-margin products could significantly drive profitability above analyst expectations. Market exits by competitors, innovation, and emerging market investments position the company for outsized growth and a strong competitive advantage.
View narrative
SEK 300
FV
25.7% undervalued intrinsic discount
6.57%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
GETI B logo
Getinge

Rising Tariffs And Regulation Will Squeeze Margins

Key Takeaways Escalating trade tensions and regulatory scrutiny are driving up costs and suppressing revenue growth, challenging profitability and supply chain stability. Market shifts toward value-based procurement and ongoing compliance issues threaten traditional revenue streams, highlighting urgent need for digital transformation and product innovation.
View narrative
SEK 165
FV
35.1% overvalued intrinsic discount
3.37%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
View Stock Community

Getinge AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Getinge
Historical stock prices
Current Share PriceSEK 222.90
52 Week HighSEK 231.60
52 Week LowSEK 164.35
Beta0.86
1 Month Change10.62%
3 Month Change13.35%
1 Year Change12.35%
3 Year Change-0.62%
5 Year Change26.43%
Change since IPO536.86%

Recent News & Updates

These 4 Measures Indicate That Getinge (STO:GETI B) Is Using Debt Reasonably Well

Oct 13
These 4 Measures Indicate That Getinge (STO:GETI B) Is Using Debt Reasonably Well

Investors Met With Slowing Returns on Capital At Getinge (STO:GETI B)

Sep 27
Investors Met With Slowing Returns on Capital At Getinge (STO:GETI B)

Recent updates

These 4 Measures Indicate That Getinge (STO:GETI B) Is Using Debt Reasonably Well

Oct 13
These 4 Measures Indicate That Getinge (STO:GETI B) Is Using Debt Reasonably Well

Investors Met With Slowing Returns on Capital At Getinge (STO:GETI B)

Sep 27
Investors Met With Slowing Returns on Capital At Getinge (STO:GETI B)

Are Investors Undervaluing Getinge AB (publ) (STO:GETI B) By 50%?

Aug 21
Are Investors Undervaluing Getinge AB (publ) (STO:GETI B) By 50%?

Market Participants Recognise Getinge AB (publ)'s (STO:GETI B) Earnings

Jul 09
Market Participants Recognise Getinge AB (publ)'s (STO:GETI B) Earnings

Getinge (STO:GETI B) Shareholders Will Want The ROCE Trajectory To Continue

May 24
Getinge (STO:GETI B) Shareholders Will Want The ROCE Trajectory To Continue

We Think Getinge (STO:GETI B) Can Stay On Top Of Its Debt

May 08
We Think Getinge (STO:GETI B) Can Stay On Top Of Its Debt

It Looks Like Getinge AB (publ)'s (STO:GETI B) CEO May Expect Their Salary To Be Put Under The Microscope

Apr 16
It Looks Like Getinge AB (publ)'s (STO:GETI B) CEO May Expect Their Salary To Be Put Under The Microscope

Getinge (STO:GETI B) Is Increasing Its Dividend To SEK4.60

Apr 10
Getinge (STO:GETI B) Is Increasing Its Dividend To SEK4.60

Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's

Mar 27
Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's

Getinge AB (publ)'s (STO:GETI B) Popularity With Investors Is Clear

Mar 24
Getinge AB (publ)'s (STO:GETI B) Popularity With Investors Is Clear

Getinge's (STO:GETI B) Soft Earnings Don't Show The Whole Picture

Feb 05
Getinge's (STO:GETI B) Soft Earnings Don't Show The Whole Picture

Does Getinge (STO:GETI B) Have A Healthy Balance Sheet?

Jan 03
Does Getinge (STO:GETI B) Have A Healthy Balance Sheet?
User avatar

Paragonix Acquisition And Defense Clearances Boost Growth In Acute Care Therapies

Strategic acquisitions and cybersecurity clearances are expected to open new revenue streams and enhance earnings.

Getinge AB (publ)'s (STO:GETI B) Price In Tune With Earnings

Dec 05
Getinge AB (publ)'s (STO:GETI B) Price In Tune With Earnings

Shareholder Returns

GETI BSE Medical EquipmentSE Market
7D2.8%2.0%2.9%
1Y12.3%-13.2%2.2%

Return vs Industry: GETI B exceeded the Swedish Medical Equipment industry which returned -12.4% over the past year.

Return vs Market: GETI B exceeded the Swedish Market which returned 2.3% over the past year.

Price Volatility

Is GETI B's price volatile compared to industry and market?
GETI B volatility
GETI B Average Weekly Movement2.8%
Medical Equipment Industry Average Movement6.5%
Market Average Movement5.5%
10% most volatile stocks in SE Market11.9%
10% least volatile stocks in SE Market2.9%

Stable Share Price: GETI B has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: GETI B's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
190411,794Mattias Perjoswww.getinge.com

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions.

Getinge AB (publ) Fundamentals Summary

How do Getinge's earnings and revenue compare to its market cap?
GETI B fundamental statistics
Market capSEK 60.71b
Earnings (TTM)SEK 2.05b
Revenue (TTM)SEK 35.85b
29.6x
P/E Ratio
1.7x
P/S Ratio

Is GETI B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GETI B income statement (TTM)
RevenueSEK 35.85b
Cost of RevenueSEK 18.95b
Gross ProfitSEK 16.91b
Other ExpensesSEK 14.85b
EarningsSEK 2.05b

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

Jan 27, 2026

Earnings per share (EPS)7.54
Gross Margin47.15%
Net Profit Margin5.73%
Debt/Equity Ratio34.0%

How did GETI B perform over the long term?

See historical performance and comparison

Dividends

2.1%
Current Dividend Yield
61%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/27 05:59
End of Day Share Price 2025/10/27 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Getinge AB (publ) is covered by 26 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Scott BardoBerenberg
Patrick Andrew WoodBofA Global Research